Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users

BACKGROUND:  We performed human immunodeficiency virus type 1 (HIV-1) transmitted/founder (T/F) virus analysis of the VAX003 vaccine efficacy trial participants to characterize the transmission bottleneck and test for vaccine-associated reduction or enhancement of infection in this injection drug us...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterrett, Sarah, Learn, Gerald H., Edlefsen, Paul T., Haynes, Barton F., Hahn, Beatrice H., Shaw, George M., Bar, Katharine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281816/
https://www.ncbi.nlm.nih.gov/pubmed/25734126
http://dx.doi.org/10.1093/ofid/ofu056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281816/
https://www.ncbi.nlm.nih.gov/pubmed/25734126
http://dx.doi.org/10.1093/ofid/ofu056

Ejemplares similares